Terminology · not a winner

DHI vs FUE

FUE names how follicular units are taken from the donor area. DHI names one way of putting them back, with a sharp implanter. The International Society of Hair Restoration Surgery says DHI is not a hair-transplant method of its own. Choosing the word on a clinic page does not establish a survival rate, a safer operation or a better cosmetic result.

No superiority claim is available from these sources

The society says an implanter may expose the bulb to less direct handling. That is not a published success rate. This page does not rank FUE, Sapphire FUE or DHI.

Society pages checked for this guide include the 18 January 2024 updates of its FUE explainers.

Extraction is not placement

What the terms refer to.

A clinic can extract with FUE and then implant with forceps, a dull implanter or a sharp implanter. The NHS still describes the donor choice as strip surgery or follicular unit extraction, and then placement into tiny cuts. It does not describe DHI as a third operation.

Question What the sources support
Extraction Follicular unit excision, still abbreviated FUE, is the donor step. The International Society of Hair Restoration Surgery describes a punch that scores and incises a follicular unit, which is then removed and stored until placement. In 2018 the society changed the formal name from “extraction” to “excision” so the step would be recognised as surgery.
Implantation Placement is a later step. The same society describes forceps into pre-made sites, stick-and-place, dull implanters into pre-made sites, and sharp implanters that make the skin opening and insert the graft together. Direct hair implantation, or DHI, is its name for sharp-implanter placement. It says DHI is not a separate hair-transplant method and should not be marketed as one.
Sapphire FUE The society lists Sapphire FUE with other marketing labels it does not recognise, including Ice FUE, Gold FUE and nano FUE. In TreatmentScope’s Turkey records, a Sapphire label is kept as a claim about the recipient-site blade unless the clinic states something more precise. The label does not change the donor method into a new operation.
What a name does not prove An implanter can avoid holding the bulb in forceps. The society calls that potentially less trauma. It does not publish a graft-survival percentage, a density advantage or a pain score for DHI versus forceps. The American Academy of Dermatology says the result depends largely on the surgeon. The NHS tells patients to ask who will do the surgery and what follow-up exists if something goes wrong.
Scarring The society says FUE does not leave the linear scar of strip surgery. It also says FUE almost always leaves small round scars, and that “no scar” advertising is false. Poorly performed excision can thin the donor area.
Who should make the openings A sharp implanter makes a skin incision. The society points patients to its statement on who is qualified to make scalp incisions, and says the doctor should be the person primarily responsible for the surgery. A method name on a package does not answer that question.

Planning

The useful distinction is the workflow, not the slogan.

Donor
Ask whether the grafts will be punch-excised one by one or taken as a strip. Those are the two donor methods the NHS and the society describe. A package that says only “DHI” has not yet said how the grafts are taken.
Recipient sites
Ask whether sites are made first, or whether a sharp implanter makes the opening as the graft goes in. Sapphire, when a clinic uses the word, is a blade claim. It is not evidence that a named doctor makes those openings.
Hair characteristics
Curl, calibre and contrast change how a result reads. They do not turn one brand name into a better operation. Afro-texture and female-pattern planning have their own Turkey research pages because the clinical questions differ, not because a different winner exists between FUE and DHI.
Outcome
No figure on this page is a graft-survival rate. The Academy says hair loss can continue after a transplant, so the design has to allow for that. A method label does not settle the design.

Turkey clinic evidence for each label stays on the FUE and DHI research pages. This comparison does not repeat those inventories.

Before you pay

Questions a method name does not answer.

  • Who punches the grafts, and is that person a doctor?
  • Who makes the skin openings, including any sharp implanter?
  • Who places the grafts if the implanter is dull and the sites were made earlier?
  • What does Sapphire refer to in this clinic’s own words?
  • What is written down for washing, flying and follow-up after you leave?

The recovery ranges that are actually published are on the recovery timeline. They are not different for the word DHI in the NHS or Academy pages used there.

What 16 indexable dossiers say

A label is not a disclosure of who operates.

The table counts 16 indexable Turkey dossiers. It is not a census of Turkish clinics, and it is not a measure of how an operation went. Each figure is a number of dossiers out of 16. The newest current observation in this reading is 5 Nov 2026. 77 stage cells have a current row. 0 are marked independently verified. The others restate what the clinic’s source says.

A cell marked not disclosed means the current source says the clinic does not disclose that stage. Unknown means a current row exists but does not name a role. No current observation means the dossier has no current sourced row for that stage. None of the three means a doctor was absent. A package that says FUE or DHI does not fill a cell. Only a current sourced statement about that stage does.

Stage Doctor Mixed team Medical team Technician Not disclosed Unknown No current observation
Consultation 13 1 2 0 0 0 0
Hairline design 10 2 0 0 2 0 2
Extraction 4 0 3 2 6 1 0
Recipient-site creation 9 1 1 1 3 0 1
Implantation 2 2 2 2 8 0 0

The clinic-by-clinic table, and the rule for what counts as current, stay on who performs the surgery. How an observation gets into that table is on methodology.

Sources

Definitions used above.

  • ISHRS: Why FUE is so confusing. Punch excision, forceps versus sharp and dull implanters, and the statement that DHI is another name for sharp-implanter placement rather than a separate method.
  • ISHRS: Surgical treatments. FUE as individual punch excision, the statement that it is still surgery, the list of unrecognised marketing names including Sapphire FUE, and the same implanter definitions.
  • ISHRS: FUE resources. The 2018 change from “extraction” to “excision”.
  • NHS: Hair transplant. Strip versus individual-graft harvesting, placement into tiny cuts, and questions to ask the surgeon.
  • American Academy of Dermatology: hair transplant. Results depend largely on the surgeon selected, and hair loss can continue.

The dossier counts are TreatmentScope’s own current reading of indexable clinic records. They are not an ISHRS statistic.